Not a good buy right now for an impatient entry: price just surged (+6.36% regular session) and is overbought (RSI-6 ~85) near R2 resistance (29.67), which increases near-term pullback risk.
Trend is bullish, but the setup looks extended; better odds come on a dip toward ~28.50 (R1) or ~26.60 (pivot) rather than chasing at ~29.35.
Insider activity is a notable headwind: insiders are selling, with selling up ~617% last month.
Short-term pattern stats also lean against buying here: model suggests ~+1.42% next day, but -1.1% next week and -7.21% next month.
Technical Analysis
Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, confirming an established uptrend.
Momentum: MACD histogram +0.281 and expanding = bullish momentum persists.
Overbought/Extension: RSI_6 = 85.457 indicates overbought conditions; rallies from here often see consolidation or pullbacks.
Levels: Pivot 26.603; Support S1 24.704 / S2 23.532; Resistance R1 28.502 / R2 29.674. With price ~29.35, it’s close to R2, limiting immediate upside versus downside.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning leans bullish: OI put/call = 0.69 (more call OI than put OI).
Flow is thin today: total option volume 7 calls / 0 puts, so the put/call volume signal is not very informative.
Volatility is relatively rich: IV30 ~55.88 vs HV ~42.22, with IV percentile ~69 → options are priced expensively (market is paying up for optionality).
Technical Summary
Sell
4
Buy
11
Positive Catalysts
Bullish technical trend (moving averages aligned) and positive MACD expansion support continuation risk to the upside.
Analyst price targets moved up recently (Citi raised PT to $38; JPM raised PT to $26), implying improving Street expectations.
Revenue growth remains positive in the latest quarter (+9.03% YoY).
Neutral/Negative Catalysts
with price near R2 resistance (29.67) → unfavorable chase risk.
2026-01-27 (JPMorgan): Neutral, PT raised $25 → $26 (more cautious; still improved estimates for FY26/FY27).
Wall Street pro view (pros/cons)
Pros: upward PT revisions and at least one firm maintaining a Buy suggest confidence in the outlook.
Cons: meaningful divergence (Buy vs Neutral, and PT spread $26 to $38) signals mixed conviction at current pricing.
Wall Street analysts forecast FOR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FOR is 32 USD with a low forecast of 25 USD and a high forecast of 36 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast FOR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FOR is 32 USD with a low forecast of 25 USD and a high forecast of 36 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 29.070
Low
25
Averages
32
High
36
Current: 29.070
Low
25
Averages
32
High
36
Citi
Anthony Pettinari
Buy
maintain
$36 -> $38
AI Analysis
2026-01-28
Reason
Citi
Anthony Pettinari
Price Target
$36 -> $38
AI Analysis
2026-01-28
maintain
Buy
Reason
Citi analyst Anthony Pettinari raised the firm's price target on Forestar Group to $38 from $36 and keeps a Buy rating on the shares.
JPMorgan
Neutral
maintain
$25 -> $26
2026-01-27
Reason
JPMorgan
Price Target
$25 -> $26
2026-01-27
maintain
Neutral
Reason
JPMorgan raised the firm's price target on Forestar Group to $26 from $25 and keeps a Neutral rating on the shares. The firm upped the company's fiscal 2026 and 2027 earnings estimates.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for FOR
